Calmark and Triolab begins negotiations for distribution in the Nordic

Calmark and Triolab begins negotiations for distribution in the Nordic

Pressmeddelanden
Press releases
Calmark Sweden AB (publ) announces today that negotiations for a Nordic market sales rights agreement regarding the Calmark NEO product are to be commenced with Triolab. A letter of intent has previously been signed by the parties.

Triolab is a leader in human diagnostics, and supplies instruments and reagents. The company also sells blood gas equipment for natal and intensive care. Triolab operates in Calmark‘s intended customer segments. A letter of intent has previously been signed by the companies.

Calmark and Triolab will enter into negotiations to sign a distributor agreement for the Nordic Region and the Baltic States.

”This is an important step forward on the eve of our upcoming launch. Triolab‘s product portfolio and customer segment match Calmark‘s well. That makes Triolab a good strategic partner, and we are pleased to proceed to the next phase of the negotations”, Anna Söderlund, CEO, says.

This information is information that Calmark Sweden AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on 16 May 2019.